Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Actas Urologicas Espanolas|January 1, 1990
[Superficial tumors of the bladder: prognostic value of the free of disease period]P Sánchez de la Muela, L Aguera Fernández, F De Castro Barbosa, et al.
Cell Cycle (Georgetown, Tex.)|August 17, 2012
Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growthDeniz A Ucar, Elena Kurenova, Timothy J Garrett, et al.
Academic Radiology|October 11, 2023
Comparison of Ultra-High-Resolution and Normal-Resolution CT-Angiography for Intracranial Aneurysm Detection in Patients with Subarachnoid HemorrhageMarius Frenzel, Felix A Ucar, Carolin Brockmann, et al.
Blood Research|September 26, 2023
ABO blood group and rhesus factor association with inpatient COVID-19 mortality and severity: a two-year retrospective reviewAlexander T Phan, Ari A Ucar, Aldin Malkoc, et al.
Frontiers in Oncology|December 20, 2018
Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical PathwaysFokhrul Hossain, Claudia Sorrentino, Deniz A Ucar, et al.
Frontiers in Immunology|September 12, 2022
Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responsesGiulia Monticone, Zhi Huang, Fred Csibi, et al.
Plos One|October 9, 2020
Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumorTiffany C Chang, Margarite D Matossian, Steven Elliott, et al.
Plos One|April 29, 2021
Correction: Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumorTiffany C Chang, Margarite D Matossian, Steven Elliott, et al.
Frontiers in Immunology|October 30, 2023
Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancerFokhrul Hossain, Deniz A Ucar, Giulia Monticone, et al.
European Review for Medical and Pharmacological Sciences|November 17, 2021
Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AMLM A Ucar, G Ozet, M B Koyuncu, et al.
Pageof 6